Entrada Therapeutics(US:TRDA) Seeking Alphaยท2025-09-25 18:57Company Overview - Entrada Therapeutics is a clinical stage biotech company focused on transforming patients' lives through innovative therapies [2] - The company has developed a proprietary technology platform known as Endosomal Escape Vehicles (EEVs), which enhances the delivery of therapeutics [2] Technology Platform - EEVs enable access to intracellular targets, which is crucial as approximately 75% of disease targets are intracellular in nature [3] - The unique chemistry of EEVs facilitates improved therapeutic delivery, making it a significant advancement in the biotech field [3] Lead Indications - Entrada's two lead indications are focused on Duchenne Muscular Dystrophy (DMD) and Myotonic Dystrophy Type 1 (DM1), highlighting the company's commitment to addressing serious genetic disorders [2]